Treatment of Infantile Hemangioma in Regional Hospitals With eHealth Support: Evaluation of Feasibility and Acceptance by Parents and Doctors

BACKGROUND: Since beta blockers became the preferred treatment for infantile hemangiomas (IH), the number of patients eligible for treatment is increasing. Currently treatment of IH with beta blockers is mainly reserved for expert centers, where wait times are lengthening. This demonstrated the need...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graaf, Marlies, Totté, Joan EE, van Os-Medendorp, Harmieke, van Renselaar, Wilco, Breugem, Corstiaan C, Pasmans, Suzanne GMA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc. 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259911/
https://www.ncbi.nlm.nih.gov/pubmed/25367558
http://dx.doi.org/10.2196/resprot.3418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259911/
https://www.ncbi.nlm.nih.gov/pubmed/25367558
http://dx.doi.org/10.2196/resprot.3418

Ejemplares similares